Abstract
Background
The currently utilized International Neuroblastoma Risk Group (INRG) staging system developed in 2009 uses image-defined risk factors as a measure of surgical risk, separating resectable neuroblastoma from those best preceded by chemotherapy. The previous International Neuroblastoma Staging System was based primarily on surgical findings. We hypothesized there would be a change to the role of the surgeon in neuroblastoma treatment in the more recent decade.
Methods
This is a single center 20-year retrospective analysis of 104 patients with International Classification of Diseases-9 and -10 codes for neuroblastoma. Patient demographics, tumor site, cancer treatment modality, survival, biopsy technique, surgical intervention, and pathology staging were collected. Data was analyzed by analysis of variance (ANOVA) and Student’s t test.
Results
There was a decrease in open surgeries for extra-adrenal neuroblastomas in the later decade (77%, 31%, P = 0.01). There was a narrowing of the time interval to surgery in the later cohort, likely as a result of uniformity in surgical timing on treatment protocols relying on INRG staging.
Conclusions
Our findings mirror changes in practice patterns globally. We found an increase in minimally invasive approaches but did not find a difference in the role of the surgeon under the INRG staging system.
Similar content being viewed by others
Data availability
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics. 2014;134:e945–55.
Parsons SK, Castellino SM, Yabroff KR. Cost, value, and financial hardship in cancer care: implications for pediatric oncology. Am Soc Clin Oncol Educ Book. 2018;38:850–60.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017;18:719–31.
Merrihew LE, Fisher PG, Effinger KE. Divergent patterns of incidence in peripheral neuroblastic tumors. J Pediatr Hematol Oncol. 2015;37:502–6.
Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49–63.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17:369–86.
Sharma R, Mer J, Lion A, Vik TA. Clinical presentation, evaluation, and management of neuroblastoma. Pediatr Rev. 2018;39:194–203.
Tsubota S, Kadomatsu K. Origin and initiation mechanisms of neuroblastoma. Cell Tissue Res. 2018;372:211–21.
Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, et al. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014;32:3169–76.
Sung KW, Yoo KH, Koo HH, Kim JY, Cho EJ, Seo YL, et al. Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features. J Korean Med Sci. 2009;24:461–7.
Davidoff AM. Neuroblastoma. Semin Pediatr Surg. 2012;21:2–14.
Sokol E, Desai AV. The evolution of risk classification for neuroblastoma. Children (Basel). 2019;6:E27.
Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009;27:289–97.
Luksch R, Castellani MR, Collini P, De Bernardi B, Conte M, Gambini C, et al. Neuroblastoma (peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163–81.
Rojas Y, Jaramillo S, Lyons K, Mahmood N, Wu MF, Liu H, et al. The optimal timing of surgical resection in high-risk neuroblastoma. J Pediatr Surg. 2016;51:1665–9.
Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, et al. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes. Pediatr Blood Cancer. 2017. https://doi.org/10.1002/pbc.26605.
Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, et al. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17:520.
Acker SN, Bruny JL, Garrington TP, Partrick DA. Minimally invasive surgical techniques are safe in the diagnosis and treatment of pediatric malignancies. Surg Endosc. 2015;29:1203–8.
Mattioli G, Avanzini S, Pini Prato A, Pio L, Granata C, Garaventa A, et al. Laparoscopic resection of adrenal neuroblastoma without image defined risk factors: a prospective study on 21 consecutive pediatric patients. Pediatr Surg Int. 2014;30:387–94.
Overman RE, Kartal TT, Cunningham AJ, Fialkowski EA, Naik-Mathuria BJ, Vasudeval SA, et al. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma. Pediatr Blood Cancer. 2020;67:e28153.
Gurria JP, Malek MM, Heaton TE, Gehred A, Lautz TB, Rhee DS, et al. Minimally invasive surgery for abdominal and thoracic neuroblastic tumors: a systematic review by the APSA Cancer committee. J Pediatr Surg. 2020;55:2260–72.
Kawano T, Souzaki R, Sumida W, Shimojima N, Hishiki T, Kinoshita Y, et al. Current thoracoscopic approach for mediastinal neuroblastoma in Japan-results from nationwide multicenter survey. Pediatr Surg Int. 2021;37:1651–8.
Kawano T, Souzaki R, Sumida W, Ishimaru T, Fujishiro J, Hishiki T, et al. Laparoscopic approach for abdominal neuroblastoma in Japan: results from nationwide multicenter survey. Surg Endosc. 2021. https://doi.org/10.1007/s00464-021-08599-4.
Ryan AL, Akinkuotu A, Pierro A, Morgenstern DA, Irwin MS. The role of surgery in high-risk neuroblastoma. J Pediatr Hematol Oncol. 2020;42:1–7.
Funding
No funding was used for this project.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. SB and PA contributed to the material preparation, data collection and analysis, and wrote the first draft of the manuscript. GCN and CR contributed to review and editing as well as supervision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.
Ethical approval
This study was approved by the Institutional Review Board (IRB#00014901).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Spencer, B., Patel, A., Cilley, R. et al. Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience. World J Pediatr 18, 120–125 (2022). https://doi.org/10.1007/s12519-021-00490-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-021-00490-5